A personalized vaccine for skin cancer shows promise at clinical trial stage
2 June - 8 minsA personalized vaccine for skin cancer could cut the risk of it returning after five years. To explain this further with Claire was Orla Dolan, CEO of Breakthrough Cancer Research.